You are here

Home > News from SGC Oxford

News from SGC Oxford

Takeda joins SGC

04/10/2012 - 14:19

Takeda Pharmaceutical Company Limited (Takeda) has joined the Structural Genomics Consortium (SGC) to fund collective drug research aimed at bringing new, more effective medicines to market faster.

More...

International Structural Genomics Consortium Announces $48.9 Million in Additional Funding to Continue the Search for New Medicines

09/28/2011 - 18:01

The international Structural Genomics Consortium (SGC) today announced $48.9 million in new funding has been attained

The Drug Discovery Unit at the University of Dundee identifies new N-myristoyltransferase inhibitors as leads to treat sleeping sickness

09/28/2011 - 12:14

"Sleeping sickness", also known as human African trypanosomiasis, is responsible for approximately 30,000 deaths each year and 70 million people are at risk of infection, as estimated by the World Health Organization

Small molecule compound used to probe into the role of Mps1

09/28/2011 - 12:13

Functional and localization experiments in mammalian cells have demonstrated that Mps1 is essential for the fidelity of the cell cycle and genomic stability.

Opening the gates for a new therapeutic opportunity in the fight against apicomplexan parasites

09/28/2011 - 12:10

Apicomplexan parasites are a diverse group of protozoan parasites, several of which cause important human and animal diseases, such as malaria, cryptosporidiosis and toxoplasmosis

SGC joins European Union Framework Programme 7 grant on Affinomics.

09/28/2011 - 12:00

The SGC has been awarded more than 0.5 M Euro as part of a joint EU FP7 -Health grant: 'Protein Binders for Characterisation of Human Proteome Function: Generation, Validation, Application "Affinomics", which encompasses 15 participant labs in eight different European countries for 5 years.

Structural Genomics Consortium releases 1000th protein structure.

09/28/2011 - 11:57

The Structural Genomics Consortium (SGC), an international public-private partnership that aims to determine three dimensional structures of medically important proteins, announced today the release into the public domain of its 1000th high resolution protein structure.

Pages

Subscribe to News from SGC Oxford